Diagnos Company Profile (TSE:ADK)

About Diagnos (TSE:ADK)

Diagnos logoAdCare Health Systems, Inc., through its subsidiaries, is a self-managed real estate investment company that invests in real estate purposed for long-term care and senior living. The Company's business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The Company owns, leases, or manages for third parties approximately 40 facilities mainly in the Southeast. Its portfolio consists of over 30 skilled nursing facilities, approximately two assisted living facilities and an independent living facility. The Company's facilities provide a range of healthcare and related services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for both long-term and short-stay patients and residents.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Home Healthcare Services
  • Sub-Industry: N/A
  • Symbol: TSE:ADK
  • CUSIP: N/A
  • Web: www.adcarehealth.com
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
  • Net Margins: 9.90%
  • Return on Assets: 2.31%

Frequently Asked Questions for Diagnos (TSE:ADK)

What is Diagnos' stock symbol?

Diagnos trades on the Tornton Stock Exchange (TSX) under the ticker symbol "ADK."

Who are some of Diagnos' key competitors?

Who are Diagnos' key executives?

Diagnos' management team includes the folowing people:

  • Allan J. Rimland, President, Chief Executive Officer, Chief Financial Officer, Director
  • E. Clinton Cain, Senior Vice President, Chief Accounting Officer, Controller
  • Krishna R. Polu M.D., Chief Medical Officer
  • Michael J. Fox, Lead Independent Director
  • David A. Tenwick, Director
  • John Laurence Clare III, Independent Director
  • Thomas W. Knaup, Independent Director
  • Brian M. Szames, Independent Director

How do I buy Diagnos stock?

Shares of Diagnos and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

MarketBeat Community Rating for Diagnos (TSE ADK)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Diagnos and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Diagnos (TSE:ADK) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Diagnos (TSE:ADK)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Diagnos (TSE:ADK)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for Diagnos (TSE:ADK)

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Diagnos (TSE:ADK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Diagnos (TSE:ADK)
Insider Trades by Quarter for Diagnos (TSE:ADK)
Insider Trades by Quarter for Diagnos (TSE:ADK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/4/2017Hébert GeorgesDirectorBuy500,000C$0.15C$75,000.00
6/12/2017Hébert GeorgesDirectorBuy485,000C$0.15C$72,750.00
5/17/2017Hébert GeorgesDirectorBuy200,000C$0.13C$26,000.00
2/3/2017Georges Lawrence HébertDirectorBuy200,000C$0.16C$32,000.00
(Data available from 1/1/2013 forward)


Headline Trends for Diagnos (TSE:ADK)
Latest Headlines for Diagnos (TSE:ADK)
marketwatch.com logoDIAGNOS Announces Restatement of March 31, 2017 Financial Statements which Resulted in a Decrease in ... - MarketWatch
www.marketwatch.com - August 29 at 3:50 PM
baystreet.ca logoDiagnos Awarded CDN$5.3-Million Contract in Mexico - Baystreet.ca
www.baystreet.ca - July 18 at 3:55 PM
benzinga.com logoDIAGNOS signs new contract valued at $ 4.16 Million USD (5.26 Million CAD) with the Government of Mexico at ... - Benzinga
www.benzinga.com - July 18 at 3:55 PM
baystreet.ca logoDiagnos Awarded CDN$5.3-Million Contract in Mexico
www.baystreet.ca - July 17 at 3:50 PM
bizjournals.com logoIIROC Trading Halt - ADK
www.bizjournals.com - July 16 at 8:24 AM
baystreet.ca logoDiagnos Deepens Roots in U.S., Opens New Clinic for Screening for Diabetic Retinopathy
www.baystreet.ca - July 5 at 3:53 PM
americanbankingnews.com logoInsider Buying: Diagnos Inc (ADK) Director Purchases 500,000 Shares of Stock
www.americanbankingnews.com - July 4 at 4:26 PM
americanbankingnews.com logoHébert Georges Buys 485,000 Shares of Diagnos Inc (ADK) Stock
www.americanbankingnews.com - June 12 at 4:38 PM
americanbankingnews.com logoInsider Buying: Diagnos Inc (ADK) Director Buys 200,000 Shares of Stock
www.americanbankingnews.com - May 18 at 10:16 AM
finance.yahoo.com logoDIAGNOS: Private Placement Closing Update - Yahoo Finance
finance.yahoo.com - April 28 at 8:42 PM
finance.yahoo.com logoDIAGNOS Announces new partnership in Bangladesh with Eyes for All - Yahoo Finance
finance.yahoo.com - April 24 at 3:21 PM
finance.yahoo.com logoDIAGNOS Announces a Contract in the Kingdom of Saudi Arabia with AlKanhoor medical Co. - Yahoo Finance
finance.yahoo.com - February 22 at 3:22 PM
finance.yahoo.com logoDIAGNOS announces contract extension with the Mexican government and an update for a two-year potential national ... - Yahoo Finance
finance.yahoo.com - February 15 at 1:35 AM



Diagnos (ADK) Chart for Monday, September, 25, 2017

This page was last updated on 9/25/2017 by MarketBeat.com Staff